Marc Hoffmann, Associate Professor; Director, Lymphoma Program

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    AbbVie
    Date added:
    04/05/2024
    Date updated:
    04/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    ADC Therapeutics
    Date added:
    04/05/2024
    Date updated:
    04/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    BeiGene
    Date added:
    04/05/2024
    Date updated:
    04/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Genentech
    Date added:
    04/05/2024
    Date updated:
    04/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astra-Zeneca
    Date added:
    04/05/2024
    Date updated:
    04/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Novartis
    Date added:
    04/05/2024
    Date updated:
    04/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Janssen
    Date added:
    04/05/2024
    Date updated:
    04/05/2024
Return to 2024 Seattle Cellular Therapy Summit: Updates and Focus on Accessibility